Deferred Tax Assets, Valuation Allowance in USD of BioCardia, Inc. from Q4 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioCardia, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2011 to Q4 2024.
  • BioCardia, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $38,497,000, a 4.9% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BioCardia, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $38,497,000 +$1,785,000 +4.9% 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q4 2023 $36,712,000 +$2,728,000 +8% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q4 2022 $33,984,000 +$2,880,000 +9.3% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q4 2021 $31,104,000 +$2,664,000 +9.4% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $28,440,000 +$3,333,000 +13% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q4 2019 $25,107,000 +$3,276,000 +15% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q4 2018 $21,831,000 +$3,166,000 +17% 31 Dec 2018 10-K 09 Apr 2020 2019 FY
Q4 2017 $18,665,000 -$2,965,000 -14% 31 Dec 2017 10-K 02 Apr 2019 2018 FY
Q4 2016 $21,630,000 +$2,760,000 +15% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q4 2015 $18,870,000 +$14,184,000 +303% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q4 2014 $4,686,000 -$89,000 -1.9% 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q4 2013 $4,775,000 -$12,000 -0.25% 31 Dec 2013 10-K 24 Mar 2015 2014 FY
Q4 2012 $4,787,000 +$162,000 +3.5% 31 Dec 2012 10-K 24 Mar 2014 2013 FY
Q4 2011 $4,625,000 31 Dec 2011 10-K 22 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.